Programming of marginal zone B-cell fate by basic Krüppel-like factor(BKLF/KLF3)

Blood

Volumn 117, Issue 14, 2011, Pages 3780-3792

  Turchinovich, Gleb ^a   Thanh, Vu Thi ^b   Frommer, Friederike ^a   Kranich, Jan ^a   Schmid, Sonja ^a   Alles, Melanie ^c   Loubert, Jean Baptiste ^d   Goulet, Jean Philippe ^d   Zimber Strobl, Ursula ^e   Schneider, Pascal ^f   Bachl, Jürgen ^e   Pearson, Richard ^b   Crossley, Merlin ^b   Fabien, Agenès ^d   Kirberg, Jërg ^a,c,f  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PAUL EHRLICH INSTITUT   (Germany)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOLLICULAR DENDRITIC CELL; GENE EXPRESSION; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 79953833433     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-308742     Document Type: Article

References (51)

1. Turner J, Crossley M. Cloning and characterization of mCtBP2, a co-repressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators. EMBO J. 1998; 17(17):5129-5140. (Pubitemid 28408479)
2. Turner J, Nicholas H, Bishop D, Matthews JM, Crossley M. The LIM protein FHL3 binds basic Kruppel-like factor/Kruppel-like factor 3 and its co-repressor C-terminal-binding protein 2. J Biol Chem. 2003;278(15):12786-12795. (Pubitemid 36800042)
3. Pearson R, Fleetwood J, Eaton S, Crossley M, Bao S. Kruppel-like transcription factors: a functional family. Int J Biochem Cell Biol. 2008;40(10): 1996-2001. (Pubitemid 352004270)
4. Carlson CM, Endrizzi BT, Wu J, et al. Kruppel-likefactor 2 regulates thymocyte and T-cell migration. Nature. 2006;442(7100):299-302. (Pubitemid 44114904)
5. Kuo CT, Veselits ML, Leiden JM. LKLF: a transcriptional regulator of single-positive T cell quiescence and survival [published correction appears in Science 278(1997):788-789].
6. Science 1997, 277, (5334) 1986-1990
7. Schober SL, Kuo CT, Schluns KS, Lefrancois L, Leiden JM, Jameson SC. Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J Immunol. 1999;163(7):3662-3667. (Pubitemid 29450887)
8. Wu J, Lingrel JB. Kruppel-like factor 2, a novel immediate-early transcriptional factor, regulates IL-2 expression in T lymphocyte activation. J Immunol. 2005;175(5):3060-3066. (Pubitemid 41170525)
9. Zhou M, McPherson L, Feng D, et al. Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo. J Immunol. 2007;178(9):5496-5504. (Pubitemid 46674344)
10. Allman D, Pillai S. Peripheral B-cell subsets. Curr Opin Immunol. 2008;20(2):149-157.
11. Lopes-Carvalho T, Foote J, Kearney JF. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol. 2005;17(3):244-250. (Pubitemid 40692658)
12. Lo CG, Lu TT, Cyster JG. Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med. 2003;197(3):353-361. (Pubitemid 36184242)
13. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 2002;297(5580):409-412. (Pubitemid 34790772)
14. Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol. 2008;9(1):54-62. (Pubitemid 350286204)
15. Cinamon G, Matloubian M, Lesneski MJ, et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol. 2004;5(7):713-720. (Pubitemid 39023303)
16. Rahman ZS, Manser T. B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers. J Immunol. 2004;173(10):6179-6188. (Pubitemid 39487775)
17. Tardivel A, Tinel A, Lens S, et al. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B-cell differentiation activity of BAFF. Eur J Immunol. 2004;34(2): 509-518. (Pubitemid 39255961)
18. Claudio E, Brown K, Park S,Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol. 2002;3(10):958-965. (Pubitemid 35154010)
19. Kayagaki N, Yan M, Seshasayee D, et al. BAFF/ BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity. 2002;17(4):515-524. (Pubitemid 35223539)
20. Sasaki Y, Derudder E, Hobeika E, et al. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity. 2006;24(6):729-739. (Pubitemid 43867365)
21. Stadanlick JE, Kaileh M, Karnell FG, et al. Tonic B cell antigen receptor signals supply an NFkappaB substrate for prosurvival BLyS signaling. Nat Immunol. 2008;9(12):1379-1387.
22. Khan WN, Alt FW, Gerstein RM, et al. Defective B cell development and function in Btk-deficient mice. Immunity. 1995;3(3):283-299.
23. Makowska A, Faizunnessa NN, Anderson P, Midtvedt T, Cardell S. CD1high B cells: a population of mixed origin. Eur J Immunol. 1999;29(10): 3285-3294. (Pubitemid 29484219)
24. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 1995;3(1):39-50.
25. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 2000;12(1):39-49. (Pubitemid 30069213)
26. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 celldevelopment in CD19-deficient mice. Nature. 1995;376(6538):352-355.
27. Samardzic T, Marinkovic D, Danzer CP, Gerlach J, Nitschke L, Wirth T. Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol. 2002;32(2):561-567. (Pubitemid 34173347)
28. Sue N, Jack BH, Eaton SA, et al. Targeted disruption of the basic Kruppel-like factor gene (Klf3) reveals a role in adipogenesis. Mol Cell Biol. 2008;28(12):3967-3978. (Pubitemid 351812983)
29. Besseyrias V, Fiorini E, Strobl LJ, et al. Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med. 2007;204(2):331-343. (Pubitemid 46294549)
30. Strasser A, Harris AW, Vaux DL, et al. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol. 1990;166:175-181.
31. Agenes F, Dangy JP, Kirberg J. T cell receptor contact to restricting MHC molecules is a prerequisite for peripheral interclonal T cell competition. J Exp Med. 2008;205(12):2735-2743.
32. Gaucher D, Therrien R, Kettaf N, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med. 2008;205(13):3119-3131.
33. SchuhW, Meister S, Herrmann K, Bradl H, Jack HM. Transcriptome analysis in primary B lymphoid precursors following induction of the pre-B cell receptor. Mol Immunol. 2008;45(2):362-375. (Pubitemid 47332648)
34. Kin NW, Crawford DM, Liu J, Behrens TW, Kearney JF. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J Immunol. 2008;180(10):6663-6674.
35. Witt CM, Won WJ, Hurez V, Klug CA. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J Immunol. 2003;171(6):2783-2788. (Pubitemid 37093496)
36. Moran ST, Cariappa A, Liu H, et al. Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. J Immunol. 2007;179(1):195-200. (Pubitemid 46986534)
37. Gray D, MacLennan IC, Bazin H, Khan M. Migrant mu+delta+ and static mu+delta+B lymphocyte subsets. Eur J Immunol. 1982;12(7):564-569.
38. Anzelon AN, Wu H, Rickert RC. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol. 2003;4(3): 287-294. (Pubitemid 36322140)
39. Suzuki A, Kaisho T, Ohishi M, et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med. 2003; 197(5):657-667. (Pubitemid 36314660)
40. Yamashita K, Sakamoto A, Ohkubo Y, et al. c-fos overexpression in splenic B cells augments development of marginal zone B cells. Mol Immunol. 2005;42(5):617-625. (Pubitemid 39655939)
41. Kirberg J, Gschwendner C, Dangy JP, Ruckerl F, Frommer F, Bachl J. Proviral integration of an Abelson-murine leukemia virus deregulates BKLF-expression in the hypermutating pre-B cell line 18-81. Mol Immunol. 2005;42(10):1235-1242.
42. Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A. BAFF controls B cell metabolic fitness through a PKC beta- and Aktdependent mechanism. J Exp Med. 2006; 203(11):2551-2562. (Pubitemid 44664624)
43. Woodland RT, Fox CJ, Schmidt MR, et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood. 2008;111(2):750-760.
44. Guo F, Weih D, Meier E, Weih F. Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. Blood. 2007;110(7):2381- 2389. (Pubitemid 47523158)
45. Li J, Peet GW, Balzarano D, et al. Novel NEMO/ IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J Biol Chem. 2001;276(21):18579-18590.
46. Khan WN. B cell receptor and BAFF receptor signaling regulation of B cell homeostasis. J Immunol. 2009;183(6):3561-3567.
47. Eaton SA, Funnell AP, Sue N, Nicholas H, Pearson RC, Crossley M. A network of Kruppellike factors (Klfs): Klf8 is repressed by Klf3 and activated by Klf1 in vivo. J Biol Chem. 2008; 283(40):26937-26947.
48. Bai A, Hu H, Yeung M, Chen J. Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol. 2007;178(12):7632-7639. (Pubitemid 46898033)
49. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol. 2008;9(3): 292-300. (Pubitemid 351267326)
50. Weinreich MA, Takada K, Skon C, Reiner SL, Jameson SC, Hogquist KA. KLF2 transcriptionfactor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity. 2009; 31(1):122-130.
51. Hoek KL, Gordy LE, Collins PL, et al. Follicular B cell trafficking within the spleen actively restricts humoral immune responses. Immunity. 2010;33(2):254-265.